#IDMastodon @lancetrespirmed #Drugdevelopment Efficacy of #ravulizumab - Inhibiting C5 in patients with severe #COVID19— The incorrect target?
📌 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00189-3/fulltext
📌 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00297-1/fulltext
📌 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00082-6/fulltext#relatedClinic
📌 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070741/

I'm now keeping an eye on: The SmPC for Ultomiris 300 mg/3 mL concentrate for solution for infusion

🏭Alexion Pharma UK Ltd

💊💉 #ravulizumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/11944/smpc

I'm now keeping an eye on: The SmPC for Ultomiris 1,100 mg/11 mL concentrate for solution for infusion

🏭Alexion Pharma UK Ltd

💊💉 #ravulizumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/11945/smpc

[Articles] Intravenous #ravulizumab in mechanically ventilated patients hospitalised with severe #COVID19: a phase 3, multicentre, open-label, randomised controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00082-6/fulltext?rss=yes